InfuSystem Holdings, Inc. (INFU)

NYSEAMERICAN: INFU · USD

$14.2

+0.07 (+0.5%)· Recorded snapshot

Market cap	282.8M
Revenue (ttm)	143.3M
Net income (ttm)	8.5M
EPS (ttm)	$0.40
Shares out	19.9M
P/E (trailing)	35.4x
P/E (forward)	29.4x
Volume	110,940
Beta	1.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 143.3M
Net income (ttm): 8.5M
EPS (ttm): $0.40
P/E (trailing): 35.4x
P/E (forward): 29.4x
Market cap: 282.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E29.4

P25 n/aP50 n/aP75 n/a

Trailing P/E35.4

P25 n/aP50 n/aP75 n/a

ROE15

P25 n/aP50 n/aP75 n/a

ROIC9.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All INFU indicators

Market & fundamental data

Available fields

271

Groups with data

Currency

USD

Showing 271 of 271 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001337013
Company name	InfuSystem Holdings, Inc.
Country	United States
Country code	US
CUSIP number	45685K102
Earnings date	2026-11-03
Earnings time	bmo
Employees	473
Employees change	-41
Employees growth	-7.98%
Enterprise value	$306.4M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US45685K1025
Last 10-K release date	2026-02-27
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$282.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$14.20
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	INFU
U.S. state	Michigan
Website	https://www.infusystem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	653.72x
Average P/E ratio (3Y)	282.18x
Average P/E ratio (5Y)	922.88x
Earnings yield	2.82%
EV/Earnings	36x
EV/EBIT	27.3x
EV/EBITDA	12.69x
EV/FCF	24.51x
EV/Sales	2.15x
FCF / EV yield	4.08%
FCF yield	4.42%
Forward EV/Sales	2.06x
Forward P/E	29.38x
Forward P/S	1.9x
Graham number	5.17546
Graham upside	-63.71%
Industry forward P/E	19.81x
Industry P/E	39.28x
Lynch fair value	$2.00
Lynch upside	-85.95%
P/(FCF - SBC) ratio	37.96x
P/(OCF - SBC) ratio	15.52x
P/B ratio	4.76x
P/E ratio	35.43x
P/FCF ratio	22.63x
P/OCF ratio	12.16x
P/S ratio	1.98x
PEG ratio	1.17x
Price / tangible book value	5.8x
Price/EBITDA ratio	11.72x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.86%
EBITDA margin	16.9%
Effective tax rate	30.04%
FCF margin	8.76%
Gross margin	57.45%
Operating margin	7.86%
Pretax margin	8.52%
Profit margin	5.96%
Profit per employee	$18,061
Profitable quarters	5
Profitable years	7
Revenue per employee	$303,034
ROA	7.09%
ROA (5Y)	3.32%
ROCE	13.67%
ROE	15.03%
ROE (5Y)	4.16%
ROIC	9.64%
ROIC (5Y)	3.68%
SBC / revenue	3.54%
Tax / revenue	2.56%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.89%
EPS growth (Q)	25%
EPS growth (QoQ)	200%
EPS growth 10Y	12.88%
EPS growth 3Y	132.79%
EPS growth 5Y	-10.43%
EPS growth quarters	6
EPS growth years	2
FCF growth	-6.21%
FCF growth (Q)	-68.36%
FCF growth 5Y	0.73%
Gross profit growth	7.93%
Gross profit growth (Q)	7.74%
Gross profit growth 3Y	10.47%
Gross profit growth 5Y	6.69%
Net income growth	68.44%
Net income growth (Q)	24.32%
Net income growth (QoQ)	217.7%
Net income growth 3Y	134.68%
Net income growth 5Y	-10.76%
Net income growth quarters	9
Net income growth years	3
OCF growth	-12.03%
OCF growth (Q)	-3.31%
OCF growth (QoQ)	598.66%
OCF growth 10Y	16.36%
OCF growth 3Y	31.3%
OCF growth 5Y	-1.21%
Operating income growth	-0.08%
Operating income growth (Q)	9.93%
Operating income growth 3Y	53.54%
Operating income growth 5Y	13.98%
Revenue growth	2.47%
Revenue growth (Q)	2.59%
Revenue growth (QoQ)	9.65%
Revenue growth 10Y	7.78%
Revenue growth 3Y	6.63%
Revenue growth 5Y	7.69%
Revenue growth quarters	1
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-10.8M
Depreciation and amortization	$13M
EBIT	$11.3M
EBITDA	$24.2M
EPS	$0.40
FCF per share	$0.63
Financing cash flow	$-14.9M
Free cash flow	$12.6M
Free cash flow minus SBC	$7.5M
Gross profit	$82.4M
Income taxes	$3.7M
Investing cash flow	$-8.2M
Net borrowing	$-5.8M
Net cash flow	$244,000
Net income	$8.5M
Operating cash flow minus SBC	$18.3M
Operating income	$11.3M
Revenue	$143.3M
Stock-based compensation	$5.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.11
Book value per share	$2.97
Debt / EBITDA	0.92
Debt / equity	0.41
Debt / FCF	1.95
Goodwill	$3.7M
Interest coverage	10.24
Long-term assets	$59.4M
Long-term liabilities	$23.3M
Net cash (debt)	$-23.6M
Net cash / market cap	-8.3%
Net debt / EBITDA	0.97
Net debt / equity	0.4
Net debt / FCF	1.88
Piotroski F-Score	8
Property, plant and equipment	$40.9M
Shareholders' equity	$59.1M
Tangible book value	$49M
Tangible book value per share	$2.46
Total assets	$97.7M
Total cash	$964,000
Total debt	$24.5M
Total liabilities	$38.6M
WACC	11.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.44
Current assets	$38.3M
Current liabilities	$15.3M
Current ratio	2.5
Inventory turnover	10.9
Net working capital	$23.3M
Quick ratio	1.91
Working capital	$23M
Working capital turnover	6.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.7%
Dividend yield	0%
Shareholder yield	3.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	468%
10Y return CAGR	18.97%
10Y total return	468%
150-day SMA	$10.81
15Y price change	1,394.74%
15Y return CAGR	19.76%
15Y total return	1,394.74%
1D price change	0.5%
1M price change	11.72%
1M total return	11.72%
1W price change	1.07%
1W total return	1.07%
1Y price change	41.86%
1Y return CAGR	41.89%
1Y total return	41.86%
20-day SMA	$13.67
200-day SMA	$10.27
20Y price change	159.6%
20Y return CAGR	4.89%
20Y total return	159.6%
3M price change	51.71%
3M total return	51.71%
3Y price change	44.6%
3Y return CAGR	13.08%
3Y total return	44.6%
50-day SMA	$12.89
50-day SMA vs 200-day SMA	50over200
52-week high	$14.41
52-week high date	2026-10-22
52-week low	$7.29
52-week low date	2026-03-02
5Y price change	-4.38%
5Y return CAGR	-0.89%
5Y total return	-4.38%
6M price change	33.21%
6M total return	33.21%
All-time high	$23.26
All-time high date	2021-03-17
All-time low	$0.75
All-time low date	2011-09-26
Average true range (ATR)	$0.48
Average volume	112.7K
Beta (1Y)	0.82
Beta (2Y)	1.74
Beta (5Y)	1.49
Change from 52-week high	-1.46%
Change from 52-week low	94.79%
Change from all-time high	-38.95%
Change from all-time low	1,793.33%
Change from open	1.43%
Day's gap	-0.92%
Dollar volume	$1.6M
High price	$14.40
Low price	$14.00
Monthly RSI	67.69
Open price	$14.00
Position in 52-week range	50%
Previous close	$14.13
Price vs 150-day SMA	31.41%
Price vs 20-day SMA	3.92%
Price vs 200-day SMA	38.24%
Price vs 50-day SMA	10.21%
Relative volume	0.99
RSI	63.97
Sharpe ratio	0.81
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	0.2
Sortino ratio	1.6
Sortino ratio (3Y)	0.88
Sortino ratio (5Y)	0.41
Volume	110.9K
Weekly RSI	72.48
YTD price change	58.31%
YTD total return	58.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18.8M
Float percentage	94.36%
Shares change (QoQ)	0.13%
Shares change (YoY)	-3.7%
Shares held by insiders	5.64%
Shares held by institutions	78.25%
Shares outstanding	19.9M
Short % of float	4.6%
Short % of shares	4.34%
Short ratio	6.2 days

Deeper analysis on INFU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INFU report

Is a complete INFU research report available?

No complete published report is available for InfuSystem Holdings, Inc. (INFU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

InfuSystem Holdings, Inc. (INFU)

Price

Financial snapshot

Fair-value bridge

Latest news · INFU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INFU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INFU

Frequently asked questions